X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hcv (3) 3
abt-450/r-ombitasvir (2) 2
genotype & phenotype (2) 2
hepatitis (2) 2
hepatitis c virus (2) 2
infections (2) 2
1-infected patients (1) 1
abridged index medicus (1) 1
adolescent (1) 1
adult (1) 1
aged (1) 1
alanine transaminase - drug effects (1) 1
anilides - administration & dosage (1) 1
antiviral agents - therapeutic use (1) 1
aspartate aminotransferases - drug effects (1) 1
biological response modifiers (1) 1
carbamates - administration & dosage (1) 1
care and treatment (1) 1
compensated cirrhosis (1) 1
daas (1) 1
dasabuvir (1) 1
drug dosages (1) 1
drug therapy (1) 1
drug therapy, combination (1) 1
drug use (1) 1
enrollments (1) 1
female (1) 1
genotype (1) 1
genotype 4 (1) 1
health aspects (1) 1
hepacivirus - genetics (1) 1
hepatitis c, chronic - drug therapy (1) 1
hepatitis c, chronic - enzymology (1) 1
hepatitis c, chronic - virology (1) 1
humans (1) 1
immunology (1) 1
index medicus (1) 1
infectious disease (1) 1
infectious diseases (1) 1
inhibitor (1) 1
interferon (1) 1
internal medicine (1) 1
ledipasvir (1) 1
liver (1) 1
liver cirrhosis (1) 1
liver diseases (1) 1
macrocyclic compounds - administration & dosage (1) 1
major (1) 1
major articles (1) 1
male (1) 1
medicine, general & internal (1) 1
microbiology (1) 1
middle aged (1) 1
ombitasvir (1) 1
opioid substitution therapy (1) 1
outcomes (1) 1
patients (1) 1
people (1) 1
plus (1) 1
pooled analysis (1) 1
protease inhibitors (1) 1
proteases (1) 1
pwid (1) 1
research article (1) 1
research articles (1) 1
ribavirin (1) 1
ribavirin - administration & dosage (1) 1
ritonavir - administration & dosage (1) 1
sofosbuvir (1) 1
treatment outcome (1) 1
virology (1) 1
virology/infectious disease (1) 1
virus diseases (1) 1
young adult (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9986, pp. 2502 - 2509
Journal Article
Health Science Reports, ISSN 2398-8835, 03/2019, Volume 2, Issue 3, pp. e92 - n/a
Background and Aims AGATE‐I Part I previously reported high sustained virologic response rates in hepatitis C genotype 4 patients with cirrhosis, with 12 and... 
DAAs | compensated cirrhosis | HCV | genotype 4 | Genotype & phenotype | Hepatitis | Liver diseases | Enrollments | Infections | Interferon | Patients | Drug dosages
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.